Location History:
- Ancaster, CN (2011)
- Ancaster, CA (2014)
Company Filing History:
Years Active: 2011-2014
Title: Keshava K S Murthy: Innovator in Pharmaceutical Chemistry
Introduction
Keshava K S Murthy is a notable inventor based in Ancaster, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. With a total of 2 patents to his name, Murthy's work has the potential to impact the medical community positively.
Latest Patents
Murthy's latest patents include innovative formulations that enhance the efficacy of existing medications. One of his notable inventions is the "Polymorphic forms of Warfarin potassium and preparations thereof." This patent provides crystalline solvate forms of Warfarin potassium, termed APO-I and APO-II, along with processes for their production. These polymorphic solvate forms are crucial for improving the drug's stability and bioavailability. Another significant patent is for "Amorphous ziprasidone hydrochloride and processes to produce the same." This invention relates to a new amorphous form of ziprasidone hydrochloride, which is essential for creating effective treatments for various mental health conditions.
Career Highlights
Keshava K S Murthy is currently associated with Apotex Pharmachem Inc., a leading company in the pharmaceutical industry. His work at Apotex has allowed him to focus on innovative drug development, contributing to the advancement of therapeutic options available to patients.
Collaborations
Murthy has collaborated with several professionals in his field, including Prabhudas Bodhuri and Gamini Weeratunga. These collaborations have fostered a productive environment for research and development, leading to groundbreaking inventions.
Conclusion
Keshava K S Murthy's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug formulations, ultimately benefiting the healthcare industry.